Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5426 Target Snapshot

Myosin light chain kinase family member 4 · SINGLE PROTEIN · Homo sapiens

333Compounds
110Assays
4Approved Drugs
170.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q86YV6. Use UniProt Q86YV6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q86YV6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Myosin light chain kinase family member 4 as ChEMBL target CHEMBL5426, mapped to UniProt Q86YV6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Myosin light chain kinase family member 4
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL5426
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q86YV6
Myosin light chain kinase family member 4
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Myosin light chain kinase family member 4 is the right protein anchor across sources, using UniProt Q86YV6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMyosin light chain kinase family member 4
UniProt AccessionQ86YV6
Component TypeProtein
Sequence Length388 aa

Myosin light chain kinase family member 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Myosin light chain kinase family member 4, mapped to UniProt Q86YV6. Sequence length is 388 aa.

Mapped IDQ86YV6
Review nameMyosin light chain kinase family member 4
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

4
Approved
3
Phase III
4
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC5047.0
KD123.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5574990 8.7 IC50 2.0 Preclinical
CHEMBL5569176 8.4 IC50 4.0 Preclinical
CHEMBL5564156 8.22 IC50 6.0 Preclinical
CHEMBL5569603 8.22 IC50 6.0 Preclinical
CHEMBL5565459 7.89 IC50 13.0 Preclinical
CHEMBL535 7.82 Kd 15.0 Approved
CHEMBL5575519 7.77 IC50 17.0 Preclinical
CHEMBL5542886 7.57 IC50 27.0 Preclinical
CHEMBL603469 7.54 Kd 29.0 Clinical
CHEMBL1721885 7.5 Kd 32.0 Clinical
Distribution

pChEMBL Value Distribution

4
5.0
4
5.5
29
6.0
4
6.5
13
7.0
10
7.5
3
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

FEDRATINIB
CHEMBL1287853
Approved 2019
MIDOSTAURIN
CHEMBL608533
Approved 2017
NINTEDANIB
CHEMBL502835
Approved 2014
SUNITINIB
CHEMBL535
Approved 2006
Assay Landscape

Assay Landscape

110
Total Assays
55
Tested Compounds
1
Assay Types
Binding — 110 assays, 55 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 86 51 6.8
assay format 21 2 5.7
cell-based format 3 2 5.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine